Glaucoma is the second leading cause of blindness in the world, according to the World Health Organization.
Chronic eye diseases such as Glaucoma, a group of eye diseases that may lead to permanent loss of vision – are still rampant. Many people around the world are diagnosed with this chronic disease and the effectiveness of current surgical treatment can only last for five years as observed from clinical data. Patients are struggling with compliance with the alternative, non-invasive treatment (i.e. eye drop).
New Technology Launching in 2017
Advanced Ophthalmic Innovations Pte Ltd (AOI) is a research and development innovation organisation with a heart. Our mission is to develop permanent solutions to prevent Glaucoma patients from losing their eyesight, and make the solution accessible and affordable to patients around the world.
We will be rolling out our flagship product – Paul® Glaucoma Implant-in the first quarter of 2017.